Compare IFS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IFS | LNTH |
|---|---|---|
| Founded | 1897 | 1956 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 2019 | 2015 |
| Metric | IFS | LNTH |
|---|---|---|
| Price | $49.79 | $66.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $48.00 | ★ $78.00 |
| AVG Volume (30 Days) | 205.7K | ★ 771.9K |
| Earning Date | 02-11-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 81.66 | N/A |
| EPS | ★ 5.02 | 2.39 |
| Revenue | ★ $1,581,287,530.00 | $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | $3.75 | $0.26 |
| P/E Ratio | ★ $10.12 | $27.58 |
| Revenue Growth | ★ 33.10 | 1.95 |
| 52 Week Low | $29.09 | $47.25 |
| 52 Week High | $52.58 | $111.29 |
| Indicator | IFS | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 70.36 | 53.26 |
| Support Level | $47.63 | $65.24 |
| Resistance Level | $52.58 | $68.70 |
| Average True Range (ATR) | 1.60 | 1.99 |
| MACD | 0.21 | -0.24 |
| Stochastic Oscillator | 64.78 | 58.06 |
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.